Cigarette smoking protects against preeclampsia but increases the risk of small-for-gestational-age birth (SGA). Regarding body weight, the converse is true: obesity elevates rates of preeclampsia but reduces rates of SGA. The authors assessed the combined effects of smoking and weight among US women developing preeclampsia or SGA, studying 7,757 healthy, primigravid women with singleton pregnancies in 1959 -1965, stratified by prepregnancy body mass index (BMI (weight (kg)/height (m) 2 ); underweight, overweight, obese), was examined in relation to preeclampsia and SGA. Among underweight (BMI <18.5) and normal-weight (BMI 18.5-24.9) women, smoking decreased the risk of preeclampsia (for heavy smoking, light smoking, nonsmoking, test for trend p ¼ 0.002 for underweight and p ¼ 0.009 for normal weight) after adjustment for age, race, and socioeconomic status. However, among overweight/obese women (BMI 25), this trend was not apparent (p ¼ 0.4). Among both underweight and overweight women, smoking significantly increased SGA risk (trend p < 0.001 for underweight and p ¼ 0.02 for overweight/obese). Obesity eliminated the inverse association between smoking and preeclampsia but did not substantially alter the positive association between smoking and SGA. A possible unifying biologic explanation is discussed in this paper. body weight; infant, small for gestational age; overweight; pre-eclampsia; pregnancy; smoking Abbreviations: BMI, body mass index; OR, odds ratio; SGA, small-for-gestational-age birth.
One of the most perplexing, yet consistent findings in reproductive epidemiology is that smoking, while elevating small-for-gestational-age birth (SGA) risk (1, 2) , protects against preeclampsia (3, 4) . In contrast, maternal overweight and obesity increase risk of preeclampsia and decrease risk of SGA (5) (6) (7) (8) (9) (10) (11) . The interaction between these two counteracting factors on these two adverse perinatal outcomes has not been well examined. Two previous studies of low birth weight showed that smoking was a risk factor for that outcome among both normal-weight and obese women (12, 13) . Two studies of preeclampsia reported discordant results: one found no differential smoking effect by weight group, whereas the other found that, among obese women, the protective effect of smoking was magnified (14, 15) . The small number of studies and their methodological limitations, including nonprospective designs and small sample sizes, leaves in question the interaction between smoking and body size.
To further assess the joint effects of smoking and weight on both preeclampsia and SGA, we used data from the Collaborative Perinatal Project, a large, US multicenter cohort of pregnant women, conducted at a time when women commonly smoked during pregnancy. Examining the joint effects of obesity, a driver of metabolic abnormalities, and smoking, a mediator of endothelial dysfunction, may shed light on the pathophysiology of both conditions (16) .
MATERIALS AND METHODS

Subjects
Details of subject selection and recruitment, data collection, and follow-up for the Collaborative Perinatal Project have been described elsewhere (17) . Briefly, women who received prenatal care at 12 hospitals from 1959 to 1965 were invited to participate. Mothers enrolled were serially followed through labor and delivery. A total of 55,908 pregnancies were included in the project.
We restricted our analyses to women with singleton pregnancies of 20 weeks' gestation (n ¼ 54,492) with their first (primigravid) pregnancy (n ¼ 15,192) registered in the first or second trimester by menstrual dating (n ¼ 11,711), with three or more prenatal visits (n ¼ 11,390), and without any of the following conditions before or during pregnancy: thrombosis, phlebitis, history of coagulation defects, diabetes mellitus, glomerulonephritis, and hydramnios (remaining n ¼ 10,834). Moreover, we excluded women with chronic hypertension or renal disease and women for whom these or smoking data were missing (remaining n ¼ 9,651). Our inclusion criteria were designed to maximize the validity of categorizing preeclampsia, which requires a finding of hypertension and proteinuria in pregnancy in a woman without preexisting elevations. It also enabled a fair assessment of whether uncomplicated overweight/obesity interacts with smoking in relation to preeclampsia and SGA. We restricted the analysis to women who had information on main exposures and outcomes of interest including smoking, weight, height, birth weight, and gestational age at delivery (calculated as the number of days between the reported date of the last menstrual period and the birth date). Finally, we compared only those women who smoked during pregnancy with never smokers, excluding past smokers from analyses because this group was too small to provide stable estimates for interaction effects. This process resulted in 7,757 women who provided the basis for this analysis.
Measurement of smoking and weight
At study entry, all enrolled women underwent a standardized interview that collected detailed demographic, socioeconomic, behavioral, and medical history information. A study physical examination was also conducted and blood and urine specimens obtained. At each subsequent prenatal visit, women were interviewed and examined.
Self-report of smoking was obtained at the entry interview and then at each prenatal visit. Women who reported smoking a total of five or more packs during their lifetime were asked about smoking duration, cessation, and dose. On the basis of this information, we categorized women as current smokers, including those who smoked at study entry, those who initiated smoking after enrollment, and those who quit during the first trimester. These women were compared with those who denied ever smoking at least five packs of cigarettes. Among current smokers, women who reported smoking 10 or more cigarettes per day at baseline were categorized as heavy smokers and women who reported smoking fewer than 10 cigarettes per day or who later in pregnancy quit or initiated smoking were categorized as light smokers.
Prepregnancy weight was recalled by participants, and height was measured at enrollment in a standardized way. Body mass index (BMI) was calculated as weight (kilograms)/height (meters) 2 . Standard cutoffs, recommended by the Centers for Disease Control and Prevention (Atlanta, Georgia), were used to group BMI into underweight (<18.5), normal weight (18.5-24.9) , and overweight/obese (25) categories (18) . The combined overweight/obese category was necessitated because there were too few obese (BMI 30) women with adverse pregnancy outcomes to provide stable estimates.
Measurement of preeclampsia and SGA
Preeclampsia was defined as an elevation in blood pressure plus proteinuria. Blood pressure was recorded at study enrollment, during each prenatal visit, during labor and delivery, and postpartum. Random urine samples were tested for albumin at each prenatal visit. The blood pressure criterion used to define preeclampsia was diastolic blood pressure of 90 mmHg in the absence of hypertension before 24 weeks' gestation or after 2 weeks postpartum (19) . Elevation in blood pressure was assessed during each of at least three measurements and had to be present on at least two occasions from 24 weeks' gestation to 2 weeks postpartum. The proteinuria criteria were 1þ on random urine dipstick testing on two occasions or 3þ on urine dipstick testing on one occasion in the absence of chronic renal disease and in the absence of proteinuria before 24 weeks' gestation or after 2 weeks postpartum. We derived the diagnosis of preeclampsia from the actual measurements at each prenatal visit and during the peripartum period rather than from summary forms completed by study obstetricians.
SGA was defined as a birth weight for gestational age below the fifth percentile. This cutoff was chosen to minimize the number of babies who were constitutively small and to maximize the number with true growth restriction (20) . Population-based and temporally appropriate birthweight-for-gestational-age nomograms by race and offspring gender classified babies in the lowest 5 percentile as an SGA (21, 22) . Women categorized as having preeclampsia accompanied by SGA were excluded from primary data analyses but were later included with the preeclampsia group in sensitivity analyses.
Covariates
Covariate information, also obtained by interview, included maternal age, race (White, Black, other), and socioeconomic status. The socioeconomic status index variable was obtained by averaging the component scores for reported education, occupation, and family income to achieve a continuous, composite numerical index (23) .
Analysis
We first compared demographic and clinical features among women who developed preeclampsia and women who developed SGA. Baseline differences between groups were analyzed with the chi-square test for categorical variables and test of trend for interval variables. Frequencies of developing preeclampsia and of developing SGA were calculated for nonsmokers, light smokers, and heavy smokers, stratified by weight (underweight, normal weight, and overweight/obese) categories. Within BMI categories, odds ratios (and 95 percent confidence intervals) were calculated by analyzing the exposure of smoking and separately the outcomes of preeclampsia and of SGA. Logistic regression models were then used to adjust for maternal age (continuous), race (Black, White, other), and socioeconomic status (continuous). Statistical significance of the smoking 3 BMI interaction term was tested in logistic models.
RESULTS
Of 7,757 healthy, primigravid women who were enrolled in the first or second trimester of pregnancy and were followed to a singleton gestation, 481 (6.2 percent) developed preeclampsia and 679 (8.8 percent) developed SGA (table 1) ; 83 (1.1 percent) developed both preeclampsia and SGA and were included in secondary analyses only. Most women at baseline were 20 years of age or younger. About 50 percent were White, 40 percent were Black, and 10 percent were of other races (mostly Puerto Rican). Over half of the women currently smoked versus never smoked. Prepregnancy underweight and overweight/obesity each affected just over one tenth of the women studied. Preeclampsia was less common and SGA more common among current smokers than nonsmokers. Preeclampsia was more common and SGA less common among overweight/obese than underweight women (figure 1). The reduced occurrence of preeclampsia and elevated occurrence of SGA among smokers was modified by weight group. Among underweight women, smoking intensity was associated with a pronounced stepwise reduction in preeclampsia, whereas, among overweight/obese women, heavy smokers and light smokers compared with nonsmokers had modest or no decreases in preeclampsia. Regarding SGA, weight group only modestly modified the increased risk associated with smoking.
After adjustment for age, race, and socioeconomic status, among underweight women (BMI <18.5), smoking decreased the risk of preeclampsia (light smokers, adjusted odds ratio (OR) ¼ 0.54; heavy smokers, adjusted OR ¼ 0. 24 for weight by current smoking were tested after adjustment for age, race, and socioeconomic status. For preeclampsia, the weight 3 smoking interaction term was significant (p ¼ 0.04); for SGA, it was not (p ¼ 0.11).
In sensitivity analyses, we added to the preeclampsia group those women who had preeclampsia complicated by SGA. Too few women had preeclampsia with SGA for meaningful stratified comparisons (only 10 were heavy smokers; only four were obese); thus, not surprisingly, adding women with preeclampsia and SGA to the preeclampsia group had no substantial impact on the odds ratios or trend tests.
DISCUSSION
The novel observation from this large, US multisite cohort study was that overweight and obesity, a strong driver of insulin resistance, hyperlipidemia, inflammation, and impaired endothelial function (24) , eliminated the protective effect of smoking on preeclampsia risk. In contrast, regardless of weight group, smoking elevated the risk of SGA. The overall trends for smoking and body size were consistent with the previous literature: smoking was associated with a dosedependent elevation in SGA and a reduction in preeclampsia, whereas obesity was more common in preeclampsia (3, 4) and less common in pregnancies complicated by SGA than in uncomplicated pregnancies (1, 2) .
Tobacco smoking causes maternal endothelial dysfunction and abnormal placentation, lesions common to preeclampsia and fetal growth restriction (25, 26) . Maternal endothelial dysfunction is present before, during, and after pregnancies complicated by both SGA and preeclampsia (27) (28) (29) . Why then does smoking have discordant effects on these two perinatal morbidities? Hypotheses regarding the protection for preeclampsia afforded by cigarettes have mostly centered on vascular explanations: hypotension from toxins such as thiocyanate, inhibition of thromboxane-induced vasoconstriction, and inhibition of anti-angiogenesis, to name a few (30) (31) (32) . However, they do not explain why cigarette smoking elevates the risk of SGA.
We previously hypothesized that 1) preeclampsia develops in the context of both maternal endothelial function and concomitant metabolic abnormalities (hyperglycemia/ hyperinsulinemia, inflammation, and hyperlipidemia) and 2) SGA develops when endothelial dysfunction is unaccompanied by metabolic abnormalities (16) . In particular, markers of endothelial dysfunction are common to both preeclampsia and SGA (e.g., prepregnancy hypertension and abnormal vascular reactivity). However, factors associated with maternal hyperglycemia/hyperinsulinemia, hyperlipidemia, and hyperinflammation are discordant for preeclampsia and SGA. Maternal obesity increases the rate of preeclampsia, and preeclamptic pregnancies demonstrate increases in all of these metabolic abnormalities, starting early in pregnancy (5-9). In contrast, underweight elevates the risk of SGA, and pregnancies resulting in SGA are characterized by lower lipid levels than those found in uncomplicated pregnancies (10, 11) .
Our data, showing that obesity eliminates the protective effect of smoking on preeclampsia, support our a priori hypothesis. Smoking can trigger elements of the metabolic syndrome (33), but smoking also has antimetabolic and, particularly, antiinflammatory effects (34, 35) . Inflammation may be the key to creating a positive feedback loop in preeclampsia; therefore, the antiinflammatory effects of smoking may curtail the progression to that outcome (16) . Underweight women have fewer metabolic abnormalities than overweight/obese women, and smokers may be doubly protected from metabolic abnormalities in pregnancy. According to our hypothesis, since preeclampsia is triggered by metabolic abnormalities, underweight smokers are protected. Among overweight/obese smokers, the antimetabolic effects of smoking counter the prometabolic effects of obesity. Preeclampsia thus occurs in overweight/obese smokers at about the same rate as it does in nonsmokers.
Previous studies examining the joint effect of smoking and obesity on low birth weight found an increased risk of cigarette use for both normal-weight and obese women (12, 13) . These results are consistent with our own, although, to our knowledge, no previous studies have examined SGA per se. Inconsistent with our findings are the results of two previous studies examining joint effects of smoking and body size on preeclampsia risk. In a study of birth certificate data from Missouri, the risk of preeclampsia was lower for women who smoked regardless of reported BMI (14) . Smoking and preeclampsia, in particular, have been shown to be poorly captured on birth certificates. Therefore, likely there was a sizable degree of misclassification in the Missouri study. Differential misclassification may have occurred if overweight/ obese women were less likely than underweight women to have smoking information recorded on birth certificates. Misclassification may have also biased the interaction effect toward the null if transient hypertension was admixed with preeclampsia more in the underweight than in the overweight/obese. Moreover, the authors did not present the smoking and preeclampsia associations stratified by BMI in adjusted models. Because our data were 1) prospective, 2) based on direct self-reports prior to outcomes, and 3) presented in adjusted models, we believe that our results are more valid than those in the prior publication.
A second study, comparing preeclampsia cases with controls from Japan, reported that, among overweight women (BMI 24), smoking was markedly more common than in nonoverweight women (15) . This study was small (71 cases), and the few overweight women provided unstable estimates.
Strengths of our study include its size, prospective design, careful outcome categorization based on repeated measures of blood pressure and urinary albumin, ability to base SGA on a low (5 percentile) standard, recall of prepregnancy weight early in pregnancy, standardized measurement of height, and structured assessment of smoking. The potential weaknesses dominantly relate to misclassification of exposures and outcomes, but these likely had little effect on our results. Smoking misclassification has been shown to be minimal in the Collaborative Perinatal Project (36). Self-reported prepregnancy weight is also a relatively accurate measure of true weight (37, 38) . Misclassification of preeclampsia was minimized by using an accepted categorization method previously published from this study (19) and by excluding women who were multiparous, multigravid, or had chronic hypertension and renal disease. Reassuringly, the incidence of preeclampsia reported here is virtually the same as that reported in two recent multicenter clinical trials (9, 39) . Because SGA categorization was based on gestational age by menstrual dating, it may have been misclassified. At the same time, misclassification was minimized by using a 5-percentile cutoff within raceand gender-specific, temporally appropriate, birth-weightfor-gestational-age nomograms. That these cutoffs categorized more than 5 percent of neonates as SGA in the Collaborative Perinatal Cohort (9.8 percent of Whites and 7.7 percent of Blacks met criteria for SGA) suggests that neonates of participating women were of lower birth weight for gestational age than would be expected in the general population of that time but does not invalidate the specificity of using these nomograms to classify growth restriction (20, 22) . A final study weakness is that this study was conducted in the 1950s-1960s, when obstetric practices and tobacco processing were different than they are today.
In summary, we found that obesity eliminated the protective effect of smoking on preeclampsia, whereas obesity did not considerably modify the association between smoking and SGA. Our data are consistent with, but cannot prove, the plausible hypothesis that preeclampsia risk is elevated by combined effects of endothelial dysfunction and metabolic abnormalities, whereas SGA risk is elevated by endothelial dysfunction alone.
